Adaptive Biotechnologies Corp. Email Format
Biotechnology ResearchWashington, United States501-1000 Employees
Adaptive Biotechnologies focuses on immune-driven medicine, seeking to translate insights from the human adaptive immune system into clinically relevant solutions. The company operates a proprietary immune profiling platform designed to reveal immune system signals at a scale and level of precision that supports research and development. Collaborating with drug developers, clinicians, and academic researchers, it aims to develop products that could improve how cancers, autoimmune diseases, and infectious diseases are diagnosed and treated. Headquartered in Seattle, Washington, Adaptive Biotechnologies sits within the biotechnology research sector and pursues applications of immune system genetics in clinical settings. With a mid-sized workforce, it emphasizes partnerships and product development for diagnostics and therapeutics rather than standalone platforms. In December 2025, the company announced a collaboration with Sanofi, illustrating ongoing industry collaborations to advance its immune-driven programs.